Hughes syndrome and Multiple sclerosis. (February 2015)

• Record Type: Journal Article
• Authors: Uthman, I; Noureldine, M H A; Berjawi, A; Skaf, M; Haydar, A A; Merashli, M; Hughes, G R V
• Is Part Of: Lupus. Volume 24:Number 2(2015)
• Page Start: 115
• Page End: 121
• Publication Date: 2015-02
• Subjects: Hughes syndrome -- antiphospholipid syndrome (APS) -- multiple sclerosis (MS) -- antiphospholipid antibodies (aPL); Systemic lupus erythematosus -- Periodicals; 616.772005
• DOI: 10.1177/0961203314555539
• Languages: English
• ISSNs: 0961-2033

Abstract

Multiple sclerosis (MS) and antiphospholipid syndrome (APS) share common clinical, laboratory and radiological features. We reviewed all the English papers on MS and APS published in the literature from 1965 to 2014 using PubMed and Google Scholar. We found that APS can mimic antiphospholipid antibodies (aPL)-positive MS in many ways in its clinical presentation. Nevertheless, APS diagnosis, clinical manifestations and management differ from those of MS. aPL were found in MS patients with titers ranging from 2% to 88%. The distribution and volume of lesions on magnetic resonance imaging (MRI) may help to differentiate MS from primary APS. In addition, atypical MS presentation can guide physicians toward an alternative diagnosis, especially when features of thrombosis and/or history of connective tissue disease are present. In that case, an anticoagulation trial could be worthwhile.